As BioInformant has grown more and more prominent within the stem cell marketplace, I am often asked about my vision for BioInformant.com and what the future will hold for our company.
Without question, my vision is to grow BioInformant.com into the largest, highest-quality provider of stem cell industry news in the world.
More specifically, I want to see BioInformant.com readership near 500,000 views per month by the end of 2017.
BioInformant’s Growth Trajectory
Over the past 12 months, our online readership has been growing exponentially, as have our email subscribers and our social media networks.The rapid growth has been exciting, and we have been adding team members quickly this year.
Because of our rapid growth, we have also had a number of clients request assistance with their own branding and communications efforts, which has added a new business area.
We remain extremely invested in our global strategic reports for the stem cell industry, because we have a highly-skilled team of researchers tracking every niche of the stem cell industry in real-time and recently surpassed a full decade of historical information on the stem cell industry (2006 to present).
A full decade of historical information on a market area is an invaluable asset and we enjoyed celebrating that achievement!
However, BioInformant has grown from a specialized provider of stem cell market news (what we were in 2006) into a broad publisher of stem cell industry news (what we are in 2016).
The global strategic reports are an important option for our clients pursuing outside funding or rapid internal growth. Similarly, the communications packages can increase any company’s presence within the marketplace.
However, my core focus is to grow BioInformant’s online publishing platform to global dominance.
How Can You Collaborate?
For this reason, we would be interested to cover your strategic alliances, your new product announcements, and your funding announcements. Our criteria for inclusion is that your announcement must substantially impact the rest of the stem cell or cord blood marketplace. If you have information about trends impacting the stem cell marketplace, we would be interested to circulate those as well.
Contact us at [email protected] to initiate a relationship with our team.
Also, make sure to join our mailing list below, because you will want to be along for the ride as we become the world’s largest and best resource for stem cell industry news.
Want to be better informed than your competition? Get future stem cell industry updates.
BioInformant is the first and only market research firm to specialize exclusively in the stem cell industry. BioInformant research has been cited by major news outlets that include the Wall Street Journal, Nature Biotechnology, Medical Ethics, Xconomy, and Vogue Magazine. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry data.